Early intermediates in HIV-1 envelope glycoprotein-mediated fusion triggered by CD4 and co-receptor complexes.
about
Involvement of Clathrin-Mediated Endocytosis in Human Immunodeficiency Virus Type 1 EntryStudy of the early steps of the Hepatitis B Virus life cycleAnti-HIV-1 activity of cellulose acetate phthalate: synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundles.Chimeric Cyanovirin-MPER recombinantly engineered proteins cause cell-free virolysis of HIV-1.Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy.The prefusogenic intermediate of HIV-1 gp41 contains exposed C-peptide regions.A novel chimeric protein-based HIV-1 fusion inhibitor targeting gp41 glycoprotein with high potency and stability.Abrogation of contaminating RNA activity in HIV-1 Gag VLPs.Targeting HIV-1 gp41-induced fusion and pathogenesis for anti-viral therapyReceptor Activation of HIV-1 Env Leads to Asymmetric Exposure of the gp41 Trimer.Conformational mapping of the N-terminal peptide of HIV-1 gp41 in lipid detergent and aqueous environments using 13C-enhanced Fourier transform infrared spectroscopyStructure-activity relationships in the binding of chemically derivatized CD4 to gp120 from human immunodeficiency virusStructural and functional properties of peptides based on the N-terminus of HIV-1 gp41 and the C-terminus of the amyloid-beta protein.Early events of HIV-1 infection: can signaling be the next therapeutic target?A peptide pertaining to the loop segment of human immunodeficiency virus gp41 binds and interacts with model biomembranes: implications for the fusion mechanism.Interaction of a peptide corresponding to the loop domain of the S2 SARS-CoV virus protein with model membranes.Sphingomyelin and cholesterol promote HIV-1 gp41 pretransmembrane sequence surface aggregation and membrane restructuring.
P2860
Q22242226-70340FC7-B83F-40EE-BCA0-CDAA69301B8EQ24791089-8AF25CDE-B3C9-4A75-8D01-7AFAE90AE596Q24791794-1ECEBF2C-8440-4B36-8B8A-4285EDFB290FQ30352110-FABA08B4-B1DC-4425-BCC2-469D7F07F43CQ30706865-6ED7399A-82E2-4CD1-9D92-D8EA4FC47831Q33211869-4D907185-EF41-4B39-B852-912A33D4E358Q34165236-9CCE58C4-6B5F-49BB-A0FF-AE2ABEAE982BQ35150217-B7A2BE2D-0504-442C-9EB8-712EAAC1B282Q35478282-90870A79-FBC8-43BC-8D0E-E94C96CAB7DEQ35615810-87BBEECB-372F-4628-9ADA-CF4B34DADB9AQ36228646-950F0033-FEF5-4063-A62A-4777340F2B2EQ36519512-972B374A-0FC2-4082-8F74-12D81F60B2A0Q36868014-B58B9072-FAC7-4AEE-907E-DC5511EC25A2Q37071276-116ED526-0CA1-40C5-BBB7-5D89F4791872Q37849655-C294DDE7-58C4-4E33-BE95-16501371CFE8Q42709844-B13D0E67-A092-4FFB-8368-12C2CF4DDAA9Q43520298-CCACDC57-8153-4DF3-BC1E-AF880411371EQ43945296-38244998-C266-4847-A88D-CB70638924DE
P2860
Early intermediates in HIV-1 envelope glycoprotein-mediated fusion triggered by CD4 and co-receptor complexes.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Early intermediates in HIV-1 e ...... CD4 and co-receptor complexes.
@en
type
label
Early intermediates in HIV-1 e ...... CD4 and co-receptor complexes.
@en
prefLabel
Early intermediates in HIV-1 e ...... CD4 and co-receptor complexes.
@en
P2093
P2860
P356
P1476
Early intermediates in HIV-1 e ...... CD4 and co-receptor complexes.
@en
P2093
Blumenthal R
Dimitrov AS
Dimitrov DS
P2860
P304
30335-30341
P356
10.1074/JBC.M103788200
P407
P577
2001-06-07T00:00:00Z